Risk factors for neuropathy in UKPDS

Risk factors for neuropathy in UKPDS

Bibliográfalaš dieđut
Váldodahkkit:	Stratton, I, Holman, R, Boulton, A
Materiálatiipa:	Conference item
Almmustuhtton:	2004

Geahča maid

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.
Dahkki: Adler, A, et al.
Almmustuhtton: (2002)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
Dahkki: Stevens, R, et al.
Almmustuhtton: (2002)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
Dahkki: Coleman, R, et al.
Almmustuhtton: (2006)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Dahkki: Kohner, E, et al.
Almmustuhtton: (2001)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
Dahkki: Holman, R, et al.
Almmustuhtton: (2001)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
Dahkki: Stevens, R, et al.
Almmustuhtton: (2001)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
Dahkki: Leal, J, et al.
Almmustuhtton: (2021)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
Dahkki: Davis, T, et al.
Almmustuhtton: (1999)

Risk factors for incident albuminuria and renal dysfunction in the UKPDS
Dahkki: Adler, A, et al.
Almmustuhtton: (2000)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Dahkki: Matthews, DR, et al.
Almmustuhtton: (1998)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
Dahkki: Stevens, R, et al.
Almmustuhtton: (2004)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
Dahkki: Stevens, R, et al.
Almmustuhtton: (2002)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
Dahkki: Stratton, I, et al.
Almmustuhtton: (2001)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
Dahkki: Kothari, V, et al.
Almmustuhtton: (2002)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
Dahkki: Widjaja, A, et al.
Almmustuhtton: (1996)

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
Dahkki: Matthews, DR, et al.
Almmustuhtton: (2004)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
Dahkki: Clarke, P, et al.
Almmustuhtton: (2004)

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
Dahkki: Widjaja, A, et al.
Almmustuhtton: (1997)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Dahkki: Alva, M, et al.
Almmustuhtton: (2014)

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
Dahkki: Turner, R, et al.
Almmustuhtton: (1998)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
Dahkki: Matthews, DR, et al.
Almmustuhtton: (1998)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
Dahkki: Horton, V, et al.
Almmustuhtton: (1999)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Dahkki: Coleman, R, et al.
Almmustuhtton: (2005)

The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results
Dahkki: Levy, J, et al.
Almmustuhtton: (1993)

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]
Dahkki: Levy, J, et al.
Almmustuhtton: (1993)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
Dahkki: Adler, A, et al.
Almmustuhtton: (2005)

Ukpds risk engine
Dahkki: Daniel Pinto
Almmustuhtton: (2011-01-01)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
Dahkki: Stratton, I, et al.
Almmustuhtton: (2006)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
Dahkki: Turner, R, et al.
Almmustuhtton: (1991)

Ethnic differences in diabetic nephropathy - The UKPDS
Dahkki: Stevens, R, et al.
Almmustuhtton: (1999)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
Dahkki: Holman, R
Almmustuhtton: (2007)

UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
Dahkki: Eeley, E, et al.
Almmustuhtton: (1996)

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
Dahkki: Coleman, R, et al.
Almmustuhtton: (2007)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
Dahkki: Gray, A, et al.
Almmustuhtton: (2001)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
Dahkki: Cull, C, et al.
Almmustuhtton: (2001)

UKPDS: what was the question? UK Prospective Diabetes Study.
Dahkki: Turner, R, et al.
Almmustuhtton: (1999)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
Dahkki: Davis, T, et al.
Almmustuhtton: (2005)

Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data
Dahkki: Coleman, R, et al.
Almmustuhtton: (2004)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
Dahkki: Cull, C, et al.
Almmustuhtton: (2004)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
Dahkki: Stratton, I, et al.
Almmustuhtton: (2000)